Earnings Ahead

CLDX - Celldex Therapeutics, Inc.

34.94 -0.4 -1.13

Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc.

About

Profile


Headquarters

Hampton, New Jersey, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

CLDX



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Celldex Non-GAAP EPS of -$0.59 misses by $0.17, revenue of $0.16M misses by $0.24M
  • Celldex begins dosing in mid-stage study of barzolvolimab for skin disorder
  • Celldex posts early-stage data to support dose-dependent effect of urticaria therapy
  • Celldex GAAP EPS of -$0.49 misses by $0.04, revenue of $0.17M misses by $0.39M
  • Celldex GAAP EPS of -$0.43 misses by $0.02, revenue of $0.33M misses by $0.84M
  • Celldex Q4 2021 Earnings Preview
  • Celldex posts preclinical data from CDX-585 PD-1/ILT4 bispecific antibody program
  • Celldex EPS misses by $0.09, misses on revenue
  • Celldex's CDX-0159 improves quality of life and reduced disease impact in urticaria patients
  • Celldex EPS beats by $0.06, beats on revenue
  • Celldex rises with bullish call from Guggenheim; potential of lead asset cited
  • Celldex Therapeutics raises $250M via equity offering
  • Celldex Therapeutics proposes $175M capital raise
  • Tempest Therapeutics, Xtant Medical leads healthcare gainers; Sigilon Therapeutics, TransMedics among major losers
  • Animal health ratings change at Guggenheim; Celldex up with positive views on trial data - today’s analyst action
  • Celldex gains over a third on early-stage data for CDX-0159 in skin condition
  • Bionano Genomics to join Russell 3000 Index, while AcelRx Pharmaceuticals to see deletion among healthcare stocks
  • Celldex EPS misses by $0.08, misses on revenue
  • Celldex EPS misses by $0.18, beats on revenue
  • Celldex reports 80% complete response rate in CDX-0159 study in skin allergy

Earnings History

Date EPS / Forecast Revenue / Forecast
November 9, 2021 -0.45 / -0.355 153K / 1.22M Beat!
August 5, 2021 -0.34 / -0.4 3.48M / 643.33K
May 6, 2021 -0.42 / -0.345 685K / 965K
March 29, 2021 -0.55 / -0.3667 3.79M / 600K
November 5, 2020 -0.36 / -0.36 668K / 395K Beat!
August 6, 2020 -0.5 / -0.58 236K / 800K
May 6, 2020 -0.73 / -0.71 2.73M / 990K
March 26, 2020 -0.64 / -0.9 887K / 815K Beat!
November 12, 2019 -0.75 / -0.96 546K / 1.26M Beat!
Date Price Open High Low Vol Change
Apr 26 36.3 36.31
36.74
35.65
325K 0.11%
Apr 25 36.26 36.29
37.15
35.86
1.0M -2.05%
Apr 24 37.02 37.87
38
36.96
395K -1.99%
Apr 23 37.77 38.91
39.67
37.62
436K -2.78%
Apr 22 38.85 38.5
39.41
37.99
552K 2.29%
 
Apr 19 37.98 38.24
38.49
36.78
593K -1.43%
Apr 18 38.53 39.41
39.94
38.29
575K -2.78%
Apr 17 39.63 39.01
40.45
38.67
955K 2.67%
Apr 16 38.6 39.03
39.27
38.14
723K -1.2%
Apr 15 39.07 39.44
40.12
38.69
409K -0.46%
Apr 12 39.25 40.53
40.86
38.56
498K -3.96%
Apr 11 40.87 39.63
41.67
39.03
596K 4.29%
Apr 10 39.19 39.33
39.44
38.1
785K -3.52%
Apr 9 40.62 39.75
40.66
39.4
488K 2.21%
Apr 8 39.74 39.89
39.89
38.89
310K 0.40%
Apr 5 39.58 39.01
40.61
38.55
483K 0.03%
Apr 4 39.57 40.83
41.49
39.43
620K -1.93%
Apr 3 40.35 40.73
41.67
40.1
821K -1.97%
Apr 2 41.16 40.65
41.37
40.07
1.3M -1.15%
Apr 1 41.64 41.84
41.84
40.53
644K -0.79%
Mar 28 41.97 41.68
42.3
41.21
580K 0.43%
Mar 27 41.79 41.33
42.38
40.66
490K 1.83%
Mar 26 41.04 41.64
41.91
40.42
481K -0.97%
Mar 25 41.44 41.94
42.85
41.26
838K -1.31%
Mar 22 41.99 41.63
42.28
40.98
672K 2.39%
Mar 21 41.01 42.71
43.42
40.93
854K -2.7%
Mar 20 42.15 40.28
42.33
39.5
923K 4.10%
Mar 19 40.49 40.9
41.38
40.33
940K -1.15%
Mar 18 40.96 42.07
42.4
40.89
960K -2.5%
Mar 15 42.01 42.23
43.21
41.67
2.3M -1.2%
Mar 14 42.52 45.05
45.05
41.6
897K -6.18%
Mar 13 45.32 46.1
47.5
45.15
1.4M -1.59%
Mar 12 46.05 46.41
47.04
45.33
726K -1.05%
Mar 11 46.54 47.5
48.37
46.44
687K -2.86%
Mar 8 47.91 47.68
49.65
47.28
884K 2.02%
Mar 7 46.96 48.57
49.06
46.84
760K -3.27%
Mar 6 48.55 49.58
50.73
48.09
1.7M -2.92%
Mar 5 50.01 50.23
50.76
48.97
2.1M -1.38%
Mar 4 50.71 53.1
53.18
49.48
2.0M -2.26%
Mar 1 51.88 47.91
52.99
47.69
3.2M 7.95%
Feb 29 48.06 51.5
51.71
46.76
1.2M -6.44%
Feb 28 51.37 51.8
52.96
50.66
991K 0.65%
Feb 27 51.04 49.13
51.64
48.8
1.9M 5.83%
Feb 26 48.23 39.22
48.96
38.96
4.8M 27.76%
Feb 23 37.75 37.55
39.08
36.6
1.2M 0.83%
Feb 22 37.44 37.36
38.04
37.08
392K -0.74%
Feb 21 37.72 38.36
39.13
37.41
510K -2.03%
Feb 20 38.5 37.94
39.13
37.94
591K 0.65%
Feb 16 38.25 36.65
38.61
36.11
1.2M 3.94%
Feb 15 36.8 36.5
37.09
35.65
855K 1.49%
Feb 14 36.26 35.85
36.61
35.36
887K 2.81%
Feb 13 35.27 35.98
36.09
35.03
549K -6.17%
Feb 12 37.59 38.04
38.54
37.56
536K -1.18%
Feb 9 38.04 37.75
38.28
37.22
491K 1.39%
Feb 8 37.52 37.7
38.01
37.17
460K -0.77%
Feb 7 37.81 37.3
38.24
37.3
579K 1.64%
Feb 6 37.2 37.39
38.03
35.88
905K 0.38%
Feb 5 37.06 35.15
37.25
35.06
699K 4.28%
Feb 2 35.54 35.25
35.87
34.65
563K 0.11%
Feb 1 35.5 35.35
36.07
35.08
859K 0%